Skip to main content
Premium Trial:

Request an Annual Quote

Alexion, Boston Univ. Develop High-Throughput Microarray Technology

Premium

N

EW HAVEN, Conn.--Alexion Pharmaceuticals announced that it has reached a milestone in the development of a novel, miniaturized, silicon-based microarray assay technology aimed at enhancing its internal drug discovery efforts. Working collaboratively with Boston University’s Department of Electrical and Computer Engineering, Alexion has established the capability to perform nanoliter volume microassays with a miniaturized, software-driven robotic system.

Stephen Squinto, Alexion’s chief technology officer, said the technology may have particular utility in areas such as genomics, single-nucleotide polymorphisms, proteomics, and screening of large recombinant protein libraries, including antibodies.

Filed under

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.